News & Events
Can Vitamin A Turn Back the Clock on Breast Cancer?
Pre-cancerous cells treated with a vitamin A derivative revert into non-cancerous cells.
Radiation Therapy and Cancer Vaccines: Timing Is Everything
Treating tumors with radiotherapy first directly kills cancer cells and makes immunotherapy more effective.
A Message from Dr. Klasko
To keep patients healthy, we’re going to need a different, friendlier, and more collaborative kind of doctor. We’re going to need to develop measurable population health strategies. And we’re going to need to make lifelong learning fun. Those innovations will help us all.
Paul Summergrad, MD, President-Elect of American Psychiatric Association to Speak at Jefferson
Paul Summergrad, MD, Chair of the Psychiatry Department of Tufts University, Psychiatrist-in-Chief at Tufts Medical Center, and President-Elect of the American...
Two Tools Are Tested to Better Understand the Effects of Concussion on Patients' Brains
Study shows potential use for cerebral blood flow and dopamine transporter imaging to evaluate T.B.I. patients.
Breast Cancer Treatment Selection Is Improved by Genomic Tests at Jefferson Breast Care Center
Molecular subtyping enables more accurate prognosis and treatment selection, according to research presented at San Antonio Conference.
Melissa A. Lazar, MD Appointed Breast Surgeon at Jefferson Breast Care Center
Thomas Jefferson University Hospital has appointed Melissa A. Lazar, MD as a surgeon at the Jefferson Breast Care Center. She has also been appointed an Assistant Professor of...
Novel Agent Set for Unique Clinical Test in Inflammatory Breast Cancer
A drug now used to treat a type of lymphoma has shown surprising benefit in preclinical studies of inflammatory breast cancer, according to a researcher at Thomas Jefferson...
Unique Partnership Lights Up a Parkinson's Disease Research Tool
NEW YORK, November 12, 2013 — The Michael J. Fox Foundation for Parkinson's Research (MJFF), Thomas Jefferson University (Jefferson) and Taconic have collaborated to create, validate and...
Cyclin D1 Governs microRNA Processing in Breast Cancer
Cyclin D1 controls cell cycle progression and microRNA biogenesis through Dicer - a new mechanism promoting breast cancer.